Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional) | PA 18 491

FAQs: NIH PA-18-491 - Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)

What is this funding opportunity?

This is an NIH discretionary grant funding opportunity titled "Studies in Neonatal and Pediatric Resuscitation (R03 - Clinical Trial Optional)" (FOA number PA-18-491; CFDA 93.865). It is intended to support smaller, focused research projects that strengthen the scientific evidence behind how newborns and children are resuscitated.

What is the main goal of the program?

The overall intent is to move the field toward more evidence-based neonatal and pediatric resuscitation practices that improve immediate survival as well as longer-term health outcomes.

What grant mechanism does this FOA use?

The FOA uses the NIH R03 mechanism, which is geared toward early-stage or tightly scoped studies that can answer practical questions, generate preliminary data, or test approaches that may later support larger clinical trials or broader implementation work.

Does an application have to include a clinical trial?

No. The FOA is designated "Clinical Trial Optional," meaning applicants are not required to propose a clinical trial. However, a clinical trial may be proposed if it fits the research question and can be conducted rigorously within the smaller R03 scope.

What research areas are considered responsive to this FOA?

The scope is intentionally broad as long as the work clearly relates to neonatal or pediatric resuscitation. The announcement highlights (among other relevant topics) fetal-to-neonatal transitional cardiovascular and pulmonary physiology, optimization of individual resuscitation steps, impacts of third-stage labor management on transition, resuscitation issues in children with congenital malformations, long-term outcomes after resuscitation, and post-resuscitation practices.

What does "fetal-to-neonatal transitional cardiovascular and pulmonary physiology" mean in this context?

It refers to how the heart and lungs adapt at birth during the transition from fetal to neonatal life, and how that physiology relates to resuscitation needs, strategies, and outcomes.

What kinds of resuscitation steps or interventions might be studied?

The FOA notes opportunities to improve and optimize individual steps in resuscitation, such as ventilation strategies, oxygen use, timing and sequencing of interventions, and decision thresholds that guide what to do next during resuscitation.

Is the program limited to delivery room resuscitation?

No. The FOA spans physiology related to the transition period, the resuscitation intervention itself, and downstream consequences, including post-resuscitation practices after return of spontaneous circulation or stabilization.

What are "post-resuscitation practices" under this FOA?

Post-resuscitation practices include what happens after return of spontaneous circulation or stabilization, such as monitoring, supportive care, and follow-up approaches.

Does the FOA encourage research on long-term outcomes?

Yes. The FOA specifically calls out interest in how resuscitation techniques may affect long-term outcomes, including neurodevelopmental, respiratory, cardiovascular, and other longer-term health trajectories.

Are studies involving children with congenital malformations within scope?

Yes. The FOA highlights resuscitation challenges in children with congenital malformations as a specifically called-out area of interest.

What study types and methods does NIH say are allowed or encouraged?

NIH signals flexibility and indicates that applications may propose epidemiologic studies (including population-level analyses and risk-factor work), animal studies using fetal-neonatal models when appropriate, computer-based or information-technology-based simulations, clinical observational studies, analyses of existing national or regional datasets, opportunistic studies, and prospective randomized controlled trials when feasible.

Can an applicant use existing datasets instead of collecting new data?

Yes. The FOA supports analyses of existing national or regional datasets, as well as clinical observational studies and other designs that leverage available data sources.

Are simulations or modeling projects eligible?

Yes. The FOA includes computer-based or information-technology-based simulations, which can include modeling, device or protocol simulations, decision support concepts, or training-related systems when linked to clinically meaningful endpoints.

Are animal studies allowed?

Yes. The FOA allows animal studies using fetal-neonatal models when appropriate for mechanistic or translational questions.

What kind of impact does NIH expect from funded projects?

NIH expects well-designed projects to help translate basic and clinical findings into resuscitation guidance that clinicians can use, ultimately improving outcomes for newborns and children across different clinical settings.

What might reviewers look for, based on the FOA description?

Based on the stated emphasis on translation into evidence-based practice, the FOA suggests reviewers will likely look for clear clinical relevance, well-justified endpoints, and a credible path from study findings to improved resuscitation protocols or post-resuscitation care.

Who is eligible to apply?

Eligibility is broad and includes many U.S.-based organizations and governmental units. The FOA lists, among others: state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; nonprofit organizations (501(c)(3) and non-501(c)(3), excluding those that are institutions of higher education where applicable); for-profit organizations other than small businesses; small businesses; eligible federal agencies; regional organizations; and U.S. territories or possessions.

Are minority-serving and capacity-building institutions explicitly included?

Yes. The FOA explicitly notes inclusion of institution types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

Are faith-based or community-based organizations eligible?

Yes. The FOA lists faith-based or community-based organizations among eligible applicant categories.

Are foreign organizations or foreign components allowed?

No. The FOA states that non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.

What does the restriction on foreign participation mean in practical terms?

Practically, it means the applicant organization must be U.S.-based and the proposed performance components must remain within allowable U.S. domestic boundaries, even if the research question has global relevance.

What is the maximum award amount mentioned for this FOA?

The source information provided indicates an award ceiling of $50,000, consistent with the R03 concept of a limited-budget, targeted project.

What are the key dates mentioned for this opportunity?

The FOA creation date listed is 2017-12-11, and the original closing date listed is 2021-01-07. The description notes that applicants would typically verify current status and any reissued versions or active receipt dates through NIH systems before preparing a submission.

What kinds of projects are a good fit for an R03 under this FOA?

Projects that are smaller in scope but likely to be meaningful, such as tightly focused studies that address practical resuscitation questions, generate preliminary data, test methods or approaches, or produce evidence that can later support larger trials or broader implementation efforts.

Is translation into clinical practice important for this FOA?

Yes. The FOA emphasizes translation into evidence-based practice, indicating the program is oriented toward findings that can inform real-world resuscitation guidance, protocols, or post-resuscitation care.

Does the FOA allow both neonatal and pediatric topics?

Yes. The FOA covers both neonatal and pediatric resuscitation, including the birth transition period for newborns and resuscitation issues affecting children more broadly.